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Abstract 
The purpose of this study is to synthesize and characterize poly (ethylene glycol) methyl ether (mPEG) conjugated 
chitosan (CS), mPEG-CS, at different ratios of 5-Fluorouracil (5-FU) delivery (5-FU-loaded mPEG-CS). The chemical 
cross-linking of these polymers were prepared by using 4-Nitrophenyl chloroformate reagent. The obtained mPEG-CS 
was characterized by Fourier transform infrared (FTIR) and proton nuclear magnetic resonance (
1
H NMR) 
spectroscopy. The 5-FU-loaded mPEG-CS particles were nearly spherical in shape with a mean diameter of 61.25 nm, 
determined by transmission electron microscopy (TEM). In addition, the entrapment efficiency of 5-FU was 
approximately 10 %. Whereas the encapsulation efficiency and loading capacity were independent of different molar 
ratios of mPEG, there was one factor that particularly stands out, which is 5-FU release behavior. These results 
indicated that mPEG-CS nanogels present the potential for controlled release of 5-FU working as a delivery system in 
cancer therapy.  




Drug delivery system (DDS) has been an 
outstanding subject of studying and developing as an 
original method to control drug release in the blood 
stream for reducing toxic side-effects in patients. 
DDS tends to particularly localize and target the 
drug within desired therapeutic range to expected 
tissue and cells while maintaining the systemic level 
of drugs [1]. In order to reach these intentions, 
nanomaterials (NMs) possess enormous advantages: 
i) protecting sensitive drug molecules from 
reticuloendothelial system (RES) in vivo, ii) 
increasing surface area between loaded drug and 
tumor tissue, iii) improving the solubility and 
bioavailability of poorly soluble drugs, iv) and 
possibility to tailor-making the drug release [2]. 
Self-assembling nanogels, one of the most effective 
NMs for ameliorating possibly drug inactivation, 
have the advantage to straightforward synthesis 
without the presence of drugs and excellent 
biocompatibility [3].  
 In comparison with artificial polymer, chitosan 
(CS) obtained by deacetylation of chitin has been 
widely used for the preparation of nanogels due to 
its unlimited in biocompatibility, biodegradability, 
hydrophilic polymer, better stability, and low 
toxicity [4-6].  However, CS is only soluble in 
aqueous acidic solution (pH < 6.5) because of a lot 
of amino groups on its chain, which may limit their 
potential clinical applications [7]. As a result, poly 
(ethylene glycol) methyl ether (mPEG), an excellent 
hydrophilic polymer, has been utilized for improving 
the stability of drug carrier systems in the blood 
circulation by enhancing water solubility of CS. 
Besides, grafting mPEG onto CS chain can not only 
optimize the biocompatibility of CS but also avoid 
the absorption of protein and evade from RES [8-
12]. 
In this study, CS and mPEG were conjugated at 
different molar ratios as controlled-release systems 
for 5-Fluorouracil (5-FU) delivery, in which CS was 
designed as cross-linker and mPEG as hydrophilic 
polymer (mPEG-CS). The obtained nanogels were 
then characterized by proton nuclear magnetic 
resonance (
1
H NMR), Fourier transform infrared 
(FTIR) spectroscopy, and transmission electron 
microscopy (TEM). Importantly, the loading capacity 
and release behavior of drug were also evaluated. This 
study is expected to create a significant opportunity for 
drug delivery in cancer therapy.  
 
2. MATERIALS AND METHODS 
 
2.1 Materials  
 
CS (Mw: 100-300 kDa, DDA: ≥ 75 %), 5-FU, 
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4-nitrophenyl chloroformate (PNC, Mw: 201.56 
Da), and poly (ethylene glycol) methyl ether 
(mPEG, Mw: 5000 Da) were purchased from Sigma-
Aldrich (St. Louis, MO, USA). All reagents and 




2.2.1. Synthesis of mPEG-PNC 
 
The preparation of mPEG-PNC is shown in Scheme 
1. Briefly, 0.25 g of mPEG was molten under 
vacuum at 65 
o
C. Then, 16 mg of PNC was added 
into the above mPEG solution and the reaction was 
kept under constant stirring (300 rpm) for 6 h. The 
mixture was left to cool at 40 
o
C for 15 min, 
followed by adding 5 mL THF to remove residual 




Scheme 1: Synthetic route for mPEG-CS 
 
2.2.2. Synthesis of mPEG-CS 
 
The CS solution (pH 5) was prepared using HCl 
(1M) solution. After that, the mPEG-PNC solution 
was added drop-wise into the CS solution and the 
reaction was kept overnight. The mixture was 
dialyzed against distilled water using Spectra/Por® 
Dialysis Membrane (MWCO: 12-14 kDa) and then 
freeze-dried to obtain mPEG-CS conjugate. The 
sample was prepared at different molar ratios (1:1, 
5:1, and 10:1) of mPEG and CS (Scheme 1).  
 
2.2.3. Drug loading content (DLC) and drug loading  
efficiency (DLE)  
Initially, 10 mg of 5-FU and 100 mg of  mPEG-CS 
conjugate were converted into liquid by deionized 
water. The mixture of both solutions was then 
sonicated for 60 min and magnetically stirred for 24 
h. The solution was later dialyzed against distilled 
water for removing free-drug. Lastly, the sample 
was obtained under solid phase by lyophilization. 
Three different mPEG-CS samples were 
dissolved independently with 1 mL CH3COOH (0.25 
M) and 1 mL acetonitrile, sonicated for 30 min, and 
then aliquots were taken out and filtered. These 
experiments were taken in triplicate for measuring 
free-5-FU concentration, which were analyzed at 
λmax = 260 nm by HPLC method. The % DLC and % 
DLE were calculated using following equations. 
 
DLE (%) = (weight of drug in particles/ weight of 
drug feed initially) × 100                                       (1) 
DLC (%) = (weight of drug in particles/ weight of 
particles and drug) × 100                                       (2) 
 
2.2.4. In vitro release 
 
The release behavior of 5-FU nanogels was carried 
out in phosphate buffer saline (PBS, 137 mmol/L 
NaCl; 2.7 mmol/L KCl; 10 mmol/L Na2HPO4; 1.8 
mmol/L KH2PO4 )  and Tween 80 (2% v/v) by 
dialysis method. 5-FU-loaded nanogels solution (25 
mg/ mL) was added into a dialysis bag (MWCO=3.5 
kDa) which was submerged fully into 12.5 mL of 
the medium at 37 
o
C with constant stirring for 12 h. 
At appropriate time intervals (2, 4, 6, 8, 10, 12 h), 
0.5 mL aliquots were withdrawn from the system 
and then filtered with 0.20 µm millipore filter. This 
experiment were repeated three times as described 
above for HPLC analysis. 
 
3. RESULTS AND DISCUSSION 
 
3.1. Characterization  
 
The mPEG-CS was characterized by 
1
H NMR 
analysis (Fig. 1). The solvent peak of D2O was 
found in 4.74 ppm. The typical peak at 3.4-3.94 ppm 
(H-b, H-c, H-d, H-e, H-2, and H-3) was assigned to 
methylene protons of CS saccharide units and repeat 
units in mPEG. Peaks at 2.95 ppm (H-c) and 3.37 
ppm (H-1) were attributed to –CH-NH- from CS and 
–OCH3 from mPEG, respectively. The peak at 1.95-
1.98 ppm (H-f) was assigned to –NH-CO-CH3. 
These results demonstrated that mPEG was 
successfully conjugated to the surface of CS. 
The FTIR spectra of mPEG-CS (i), CS (ii), and 
mPEG (iii) are presented in Fig. 2. The spectrum of 
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(amide I), 1594 cm
-1
 (-NH2 bending), and 1400 cm
-1
 
(amide III) (Fig. 2ii). The absorption bands at 1150 
cm
-1
 (asymmetric stretching of the COOOC bridge), 
1092, and 1042 cm
-1
 (skeletal vibration involving the 
COO stretching) were assigned to its saccharine 
structure. In addition, the increased intensity of the 
peaks at around 2910 and 2830, and 1094 cm
–1 
show 
the CH2 groups, and C-O-C stretch of mPEG, 
respectively (Fig. 2iii). As shown in Fig. 2i, the CS 
amide peaks slightly shifted to 1631 cm
-1
 and 1529 
cm
-1
, respectively. The shifts were possibly due to 
hydrogen bonding between amide carbonyl with 
mPEG hydroxyl. The increased intensity of the 
peaks at around 2924 cm
-1
 and 1100 cm
-1
 indicated 
the CH2 groups and C-O-C stretch of mPEG, 
respectively. These results indicated that mPEG-CS 




Figure 1: 1H NMR spectrum of mPEG-CS 
 
The particle size of mPEG-CS nanogels was 
found to be nearly spherical in shape (Fig. 3a) with 
an average diameter of 61.25 nm (Fig. 3b). 
According to previous reports, nanoparticles are 
ranging from 20 nm to 100 nm in size that are 
preferred to accumulate in solid tumors caused by 





Figure 2: FTIR spectra of (i) mPEG-CS, (ii) CS and 
(iii) mPEG 
The small size allows prolonged circulation half-life 
of the drug, providing more opportunities for 
nanoparticles to accumulate at the target site. 
Therefore, 5-FU-loaded mPEG-CS nanogels might 




Figure 3: (a) TEM image and (b) particle size 
distribution of 5-FU-loaded mPEG-CS nanogels 
 
3.2. Drug loading and release behavior  
 
The DLE of 5-FU-loaded mPEG-CS nanogels were 
11.5 % at mPEG-CS (1:1), 10.0 % at mPEG-CS 
(5:1), and 10.39 % at mPEG-CS (10:1). There were 
no significant differences of 5-FU loading among 
mPEG-CS ratios, which means DLE and DLC of the 
drug did not depend on different quantifications of 
mPEG over CS.  
 The in vitro release behavior of 5-FU was carried 
out in PBS (pH 7.4) at 37 
o
C (Fig. 4). The release of 
5-FU from mPEG-CS nanogels (1:1) was 23 % at 2 
h, and then increased to 39% at 4 h. The release of 
drug was later relatively slow up to 12 h (41 %), 
only 2 % 5-FU was released during that period of 
time. The release of 5-FU released from mPEG-CS 
(5:1) was 17 % at 2 h and 33 % at 4 h. After 12 h, 37 
% 5-FU was slowly delivered. In comparison with 
mPEG-CS (10:1), the drug was rapidly freed up 94%  
at 12 h. Based on these results, mPEG-CS (1:1) and 
mPEG-CS (5:1) were suitable for prolonged release, 
rather than mPEG-CS (10:1), the highest 
performance mPEG.  
  




Figure 4: Drug release of mPEG-CS at different 
ratios Square:mPEG-CS (1:1); triangular:mPEG-CS 




According to the results of 
1
H NMR and FTIR 
analysis, 5-FU-loaded mPEG-CS nanogels were 
successfully synthesized. The particle size of 
nanogels was nearly spherical in shape with an 
average diameter of 61.25 nm. In addition, 5-FU was 
relatively loaded into mPEG-CS nanogels and the 
release behavior of 5-FU showed that mPEG-CS 
(1:1) and mPEG-CS (5:1) have great potential as 
controlled delivery system in cancer therapy.  
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